Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Stravalaci M, Pagani I, Paraboschi E, Pedotti M, Doni A, Scavello F, Mapelli S, Sironi M, Perucchini C, Varani L, Matkovic M, Cavalli A, Cesana D, Gallina P, Pedemonte N, Capurro V, Clementi N, Mancini N, Invernizzi P, Bayarri-Olmos R, Garred P, Rappuoli R, Duga S, Bottazzi B, Uguccioni M, Asselta R, Vicenzi E, Mantovani A, Garlanda C. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nature Immunology 2022, 23: 275-286. PMID: 35102342, DOI: 10.1038/s41590-021-01114-w.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsC-Reactive ProteinCase-Control StudiesChlorocebus aethiopsComplement ActivationCoronavirus Nucleocapsid ProteinsCOVID-19FemaleGlycosylationHEK293 CellsHost-Pathogen InteractionsHumansImmunity, HumoralMaleMannose-Binding LectinPhosphoproteinsPolymorphism, GeneticProtein BindingReceptors, Pattern RecognitionSARS-CoV-2Serum Amyloid P-ComponentSignal TransductionSpike Glycoprotein, CoronavirusVero CellsConceptsFluid phase pattern recognition moleculesPattern recognition moleculesHumoral fluid phase pattern recognition moleculesMannose-binding lectinSARS-CoV-2Pentraxin 3Severe acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Spike proteinDisease severity biomarkersSyndrome coronavirus 2Coronavirus disease 2019Long pentraxin 3Antibody-like functionsVariants of concernRecognition moleculesHumoral armSeverity biomarkersCoronavirus 2Disease 2019Innate immunityDisease severityComplement activationTranslational implications
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply